SCHEMBL10654147

SCHEMBL10654147

CCCCn1c(C)c(CC)c2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PGR P06401 3/20 0.55
RORA P35398 3/20 0.55
RORC P51449 3/20 0.55
RORB Q92753 3/20 0.55
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HPGD P15428 2/20 0.54
LMNA P02545 1/20 0.54
CNR2 P34972 12/20 0.52
CNR1 P21554 7/20 0.52
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SLC6A3 Q01959 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27799854 0.87 ALDH1A1 (0.55) PGRRORARORCRORBALDH1A1
SCHEMBL13490798 0.84 ALDH1A1 (0.51) PGRRORARORCRORBALDH1A1
SCHEMBL27799843 0.83 PGR (0.52) PGRRORARORCRORBALDH1A1
SCHEMBL11681291 0.82 ALDH1A1 (0.53) PGRALDH1A1KDM4EHPGDTDP1
SCHEMBL28174704 0.82 CNR2 (0.58) PGRRORARORCRORBALDH1A1
Ammonia Solution, Strong SCHEMBL27949259 0.81 ALDH1A1 (0.52) PGRALDH1A1KDM4EHPGDTDP1
SCHEMBL1335135 0.80 PGR (0.73) PGRRORARORCRORBALDH1A1
SCHEMBL29531665 0.80 PGR (0.73) PGRRORARORCRORBALDH1A1
SCHEMBL9657145 0.79 PGR (0.54) PGRRORARORCRORBALDH1A1
SCHEMBL6013329 0.78 KDM4E (0.59) PGRRORARORCRORBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0243122-A2 Piperazine compound as PAF-antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-10-28 EP claimed
EP-0243122-A3 Piperazine compound as PAF-antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-07-13 EP disclosed
EP-0243122-A2 Piperazine compound as PAF-antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-10-28 EP disclosed